Federal Agency for Medicines and Health Products

The Federal Agency for Medicines and Health Products (FAMHP) of Belgium is responsible for the approval and registration of new medication in Belgium and for pharmacovigilance. Xavier De Cuyper is General Administrator of the agency.

Federal Agency for Medicines and Health Products
Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (in Dutch)
Agence fédérale des médicaments et des produits de santé (in French)
Agency overview
FormedJanuary 1, 2007 (2007-01-01)
Preceding
  • Directorate-general for Medicines (Federal Public Service Health)
Jurisdiction Belgium
HeadquartersSaint-Gilles, Brussels
Employees458 (anno 2016)
Annual budgetCa. 70,000,000 EUR
Minister responsible
Agency executive
  • Xavier De Cuyper, Administrator-general
Parent departmentFederal Public Service Health
Websitewww.famhp.be

The Dutch name is Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG) and in French it is called Agence Fédérale des Médicaments et des Produits de Santé (AFMPS).

The agency succeeded the Directoraat-generaal Geneesmiddelen / Direction Générale des Médicaments of the Federal Public Service Health as the new Competent Authority on 1 January 2007.

See also
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.